Alzheimer's disease (AD) is a progressive neurodegenerative disorder in which amyloid β accumulation, tau pathology, chronic neuroinflammation, and metabolic stress converge to drive synaptic dysfunction and neuronal loss. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.